Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $49.24 USD
Change Today 0.00 / 0.00%
Volume 0.0
As of 8:10 PM 05/21/15 All times are local (Market data is delayed by at least 15 minutes).

Insiders at takeda pharmaceutical co ltd (TKPHF)

Name (Connections)Board RelationshipsTitleType of Board MemberAge
Christophe Weber 18 RelationshipsChief Executive Officer, President and Representative DirectorChief Executive Officer48
Francois-Xavier Roger 18 RelationshipsChief Financial Officer, Senior Vice President and DirectorChief Financial Officer52
Tadataka Yamada M.D.124 RelationshipsChief Medical & Scientific Officer, Director and Executive Vice President of Takeda Pharmaceuticals International, IncSenior Key Executive68
Yasuhiko Yamanaka 18 RelationshipsManaging Director of Special Missions and DirectorSenior Key Executive--
Shinji Honda 33 RelationshipsSenior Managing Director, Senior Vice President, Corporate Strategy Officer, Director and President of Takeda Pharmaceuticals International, Inc Unit President49
Masato Iwasaki Ph.D.18 RelationshipsDirector and President of Japan Pharma Business Unit Unit President--

Other Board Members on Board*

Name (Connections)Board RelationshipsType of Board MemberPrimary CompanyAge
Yasuchika Hasegawa 46 RelationshipsChairman of the BoardTakeda Pharmaceuticals International GmbH68
Bruno Angelici MBA 51 RelationshipsMember of Advisory BoardWolters Kluwer NV67
Karen Katen 223 RelationshipsMember of Advisory BoardEssex Woodlands Health Ventures65
Sidney Taurel 154 RelationshipsMember of Advisory BoardCapital Royalty L.P65
Fumio Sudo 52 RelationshipsMember of the Board of DirectorsJFE Holdings, Inc.72
Yorihiko Kojima 135 RelationshipsMember of the Board of DirectorsMitsubishi Corporation73
William Chin M.D. 70 RelationshipsMember of Advisory BoardTakeda Pharmaceutical Company Limited--
Masahiro Sakane 56 RelationshipsMember of the Board of DirectorsAsunaro Aoki Construction Co.,Ltd.73
Naohisa Takeda 18 RelationshipsMember of Audit CommitteeTakeda Pharmaceutical Company Limited--
Teruo Sakurada 18 RelationshipsMember of Audit CommitteeTakeda Pharmaceutical Company Limited--
Tsuguoki Fujinuma 95 RelationshipsMember of Audit CommitteeNomura Holdings, Inc.70
Shiro Kuniya 54 RelationshipsMember of Audit CommitteeNEXON Co., Ltd.57
Katsushi Kuroda 33 RelationshipsMember of Audit CommitteeUniden Corporation67
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
TKPHF:US $49.24 USD 0.00

TKPHF Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Abbott Laboratories $49.03 USD -0.31
Baxter International Inc $67.37 USD -0.17
Becton Dickinson and Co $141.94 USD -0.47
Biogen Inc $398.68 USD -2.47
Merck KGaA €101.23 EUR -0.229
View Industry Companies
 

Industry Analysis

TKPHF

Industry Average

Valuation TKPHF Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 2.6x
Price/Book 2.2x
Price/Cash Flow NM Not Meaningful
TEV/Sales 1.8x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact TAKEDA PHARMACEUTICAL CO LTD, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.